SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-204366
Filing Date
2013-05-07
Accepted
2013-05-07 16:01:27
Documents
10
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d527262d10q.htm 10-Q 589900
2 EX-31.1 d527262dex311.htm EX-31.1 6010
3 EX-31.2 d527262dex312.htm EX-31.2 6236
4 EX-32.1 d527262dex321.htm EX-32.1 4548
  Complete submission text file 0001193125-13-204366.txt   4054783

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ziop-20130331.xml EX-101.INS 481575
6 XBRL TAXONOMY EXTENSION SCHEMA ziop-20130331.xsd EX-101.SCH 46322
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ziop-20130331_cal.xml EX-101.CAL 40511
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ziop-20130331_def.xml EX-101.DEF 257347
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ziop-20130331_lab.xml EX-101.LAB 378493
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ziop-20130331_pre.xml EX-101.PRE 296966
Mailing Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036
Business Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036 646-214-0700
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33038 | Film No.: 13819889
SIC: 8093 Services-Specialty Outpatient Facilities, NEC